Literature DB >> 2452112

Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase.

C V Dang1, E M Tan, J A Traugh.   

Abstract

Spontaneously occurring autoantibody to threonyl-tRNA synthetase found in the serum of patients with polymyositis and experimentally induced antibody against highly purified rabbit reticulocyte threonyl-tRNA synthetase were used to analyze the epitopes of threonyl-tRNA synthetase. The PL-7 autoantibody reacted with the native but not the denatured form of threonyl-tRNA synthetase, whereas the experimentally induced antibody recognized both the native and denatured forms of the enzyme. In addition, the PL-7 autoantibody specifically inhibited threonyl-tRNA synthetase activity whereas the experimentally induced antibody had no effect on aminoacylation. Thus, the epitopes recognized by the PL-7 autoantibody are formed by the tertiary structure of the enzyme and are associated with the catalytic site of the synthetase whereas the experimentally induced antibody recognizes epitopes formed by primary sequences not related to the catalytic function of the synthetase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452112     DOI: 10.1096/fasebj.2.8.2452112

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

Review 1.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

2.  Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.

Authors:  William K Decker; Dongxia Xing; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Krishna V Komanduri; Elizabeth J Shpall
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

3.  Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.

Authors:  B Grigolo; I Mazzetti; R M Borzì; I D Hickson; M Fabbri; L Fasano; R Meliconi; A Facchini
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 4.  Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.

Authors:  I N Targoff; E P Trieu; F W Miller
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  Autoimmune response to the Ro/SSA particle is directed to the human antigen.

Authors:  M Reichlin; M Rader; J B Harley
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.

Authors:  P Sié; A Bezeaud; D Dupouy; G Archipoff; J M Freyssinet; J M Dugoujon; G Serre; M C Guillin; B Boneu
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 8.  Diversity and origin of rheumatologic autoantibodies.

Authors:  M J Fritzler; M Salazar
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly.

Authors:  K Miyachi; Y Hirano; T Horigome; T Mimori; H Miyakawa; Y Onozuka; M Shibata; M Hirakata; A Suwa; H Hosaka; S Matsushima; T Komatsu; H Matsushima; R W Hankins; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 10.  Autoantibodies to tumor-associated antigens: reporters from the immune system.

Authors:  Eng M Tan; Jianying Zhang
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.